Chronic Pain
The best-studied use of cannabis. Effects are real but small — relief for many, a cure for none.
Pain Moderate
What the research says
A 2021 BMJ meta-analysis of 32 randomized trials (over 5,000 patients) found that oral medical cannabis probably produces a small improvement in pain — about a 10% greater chance of meaningful relief versus placebo. The same review found only a very small improvement in physical functioning, and no meaningful change in mood or social functioning.
The expert panel behind the study issued a 'weak recommendation' for a trial of cannabis — meaning for some people it helps enough to be worth trying, but the average benefit is modest and the side effects (dizziness, drowsiness, nausea, cognitive fuzziness) are common.
Bottom line: cannabis is a reasonable tool for chronic pain, but the honest framing is 'helps some, modestly' — not 'eliminates pain.' It is not a replacement for standard care.
The honest caveats
Most trials used oral products (oils, capsules), not inhaled flower. Effects take 30–90 minutes and can be unpredictable. There is no good evidence that higher doses work better — and more THC means more side effects. Talk to your clinician, especially if you take other medications.
Compounds to explore
These are the compounds — terpenes and cannabinoids — that the research connects to this condition. They are starting points for reading a COA or choosing a product, not prescriptions. Each has its own guide with more detail.
Cannabinoid THC The main driver of pain relief in most trials, especially at moderate doses. Cannabinoid CBD Non-intoxicating; studied for pain, often combined with THC. Terpene beta-caryophyllene A strong anti-inflammatory terpene that binds directly to CB2 receptors. Terpene myrcene Common sedating terpene that pairs well with pain relief at night. Cannabinoid CBDVA Inhibits T-type calcium channels — a mechanism relevant to pain signaling; laboratory evidence. Cannabinoid CBNA A pilot study found antinociception in mice comparable to THC — early, preclinical data. Terpene borneol Antinociceptive and anti-inflammatory in a mouse study — a traditional pain remedy with lab support. Terpene camphene Produced antinociceptive (pain-relieving) activity in a 2013 mouse study. Terpene 3-carene Anti-inflammatory and antinociceptive activity in laboratory and animal models. Terpene geranyl acetate Antinociceptive and antioxidant activity measured in a mouse study of common terpenes. Terpene caryophyllene oxide Anti-inflammatory and pain-relieving potential flagged in the entourage literature. Cannabinoid THCA Raw, non-intoxicating precursor to THC; anti-inflammatory and neuroprotective in early lab research.Sources for this condition
- https://www.bmj.com/content/374/bmj.n1034
- https://journals.lww.com/pain/fulltext/2021/07001/international_association_for_the_study_of_pain.1.aspx
- https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.1048259/full
- https://pubmed.ncbi.nlm.nih.gov/34897062/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC3654274/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC3658412/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC6308289/